Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heath-Chiozzi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Trends in Molecular Medicine|April 28, 2001
Clinical application of pharmacogeneticsB B Spear, M Heath-Chiozzi, J Huff
Hawaii Medical Journal|June 1, 1996
PPD skin reactivity and anergy in HIV-infected patients in HawaiiC M Shikuma, S Congdon, N Hanks, et al.
AIDS (London, England)|November 14, 1998
Individual prognoses of long-term responses to antiretroviral treatment based on virological, immunological and pharmacological parameters measured during the first week under therapyB U Mueller, S L Zeichner, V A Kuznetsov, et al.
Lancet (London, England)|March 11, 1998
Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study GroupD W Cameron, M Heath-Chiozzi, S Danner, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeksC P Raines, C Flexner, E Sun, et al.
The Journal of Infectious Diseases|March 9, 1999
Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end pointsH Wu, D R Kuritzkes, D R McClernon, et al.
AIDS (London, England)|March 14, 2000
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials GroupH Valdez, K Y Smith, A Landay, et al.
The Journal of Infectious Diseases|February 10, 1999
The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responsesM Markowitz, M Vesanen, K Tenner-Racz, et al.
Pediatrics|March 14, 1998
A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infectionB U Mueller, R P Nelson, J Sleasman, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Trends in Molecular Medicine|April 28, 2001
Clinical application of pharmacogeneticsB B Spear, M Heath-Chiozzi, J Huff
Hawaii Medical Journal|June 1, 1996
PPD skin reactivity and anergy in HIV-infected patients in HawaiiC M Shikuma, S Congdon, N Hanks, et al.
AIDS (London, England)|November 14, 1998
Individual prognoses of long-term responses to antiretroviral treatment based on virological, immunological and pharmacological parameters measured during the first week under therapyB U Mueller, S L Zeichner, V A Kuznetsov, et al.
Lancet (London, England)|March 11, 1998
Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study GroupD W Cameron, M Heath-Chiozzi, S Danner, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 15, 2000
Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeksC P Raines, C Flexner, E Sun, et al.
The Journal of Infectious Diseases|March 9, 1999
Characterization of viral dynamics in human immunodeficiency virus type 1-infected patients treated with combination antiretroviral therapy: relationships to host factors, cellular restoration, and virologic end pointsH Wu, D R Kuritzkes, D R McClernon, et al.
AIDS (London, England)|March 14, 2000
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials GroupH Valdez, K Y Smith, A Landay, et al.
The Journal of Infectious Diseases|February 10, 1999
The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responsesM Markowitz, M Vesanen, K Tenner-Racz, et al.
Pediatrics|March 14, 1998
A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infectionB U Mueller, R P Nelson, J Sleasman, et al.
Pageof 1